Literature DB >> 21136891

Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancer.

Judith Y M N Engwegen1, Marieke Alberts, Jaco C Knol, Connie R Jimenez, Annekatrien C T M Depla, Henriëtte Tuynman, Henk A van Heukelem, Pleun Snel, Marianne E Smits, Annemieke Cats, Jan H M Schellens, Jos H Beijnen.   

Abstract

Entities:  

Year:  2008        PMID： 21136891     DOI： 10.1002/prca.200780068

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN： 1862-8346            Impact factor:   3.494


× No keyword cloud information.
  10 in total

1.  Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers.

Authors:  Irene van den Broek; Rolf W Sparidans; Jan H M Schellens; Jos H Beijnen
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

2.  Isothermal vitrification methodology development for non-cryogenic storage of archival human sera.

Authors:  Rebekah Less; Kristin L M Boylan; Amy P N Skubitz; Alptekin Aksan
Journal:  Cryobiology       Date:  2013-01-24       Impact factor: 2.487

3.  Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry.

Authors:  Dongjian Song; Lifang Yue; Junjie Zhang; Shanshan Ma; Wei Zhao; Fei Guo; Yingzhong Fan; Heying Yang; Qiuliang Liu; Da Zhang; Ziqiang Xia; Pan Qin; Jia Jia; Ming Yue; Jiekai Yu; Shu Zheng; Fuquan Yang; Jiaxiang Wang
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

4.  Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.

Authors:  Annemieke W J Opstal-van Winden; Esmeralda J M Krop; Monica H Kåredal; Marie-Christine W Gast; Christian H Lindh; Marina C Jeppsson; Bo A G Jönsson; Diederick E Grobbee; Petra H M Peeters; Jos H Beijnen; Carla H van Gils; Roel C H Vermeulen
Journal:  BMC Cancer       Date:  2011-08-26       Impact factor: 4.430

5.  Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.

Authors:  Francisca Barceló; Joan J Cerdà; Antonio Gutiérrez; Teresa Jimenez-Marco; M Antonia Durán; Andrés Novo; Teresa Ros; Antonia Sampol; José Portugal
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

6.  Time course analysis based on gene expression profile and identification of target molecules for colorectal cancer.

Authors:  Guoting Chen; Ning Han; Guofeng Li; Xin Li; Guang Li; Zengchun Li; Qinchuan Li
Journal:  Cancer Cell Int       Date:  2016-03-24       Impact factor: 5.722

7.  A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.

Authors:  Annemieke W J Opstal-van Winden; Wendy Rodenburg; Jeroen L A Pennings; Conny T M van Oostrom; Jos H Beijnen; Petra H M Peeters; Carla H van Gils; Annemieke de Vries
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

8.  Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study.

Authors:  Annemieke W J van Winden; Marie-Christine W Gast; Jos H Beijnen; Emiel J Th Rutgers; Diederick E Grobbee; Petra H M Peeters; Carla H van Gils
Journal:  BMC Med Genomics       Date:  2009-01-19       Impact factor: 3.063

9.  Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk.

Authors:  Judith Y M N Engwegen; Annekatrien C T M Depla; Marianne E Smits; Annemieke Cats; Henriëtte Tuynman; Henk A van Heukelem; Pleun Snel; Wouter Meuleman; Lodewyk F Wessels; Jan H M Schellens; Jos H Beijnen
Journal:  Biomark Insights       Date:  2008-07-02

10.  Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry.

Authors:  Dongjian Song; Lifang Yue; Hao Li; Junjie Zhang; Zechen Yan; Yingzhong Fan; Heying Yang; Qiuliang Liu; Da Zhang; Ziqiang Xia; Pan Qin; Jia Jia; Ming Yue; Jiekai Yu; Shu Zheng; Fuquan Yang; Jiaxiang Wang
Journal:  Br J Cancer       Date:  2016-03-22       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.